Menu
Genomill and Finland’s Cancer Research Flagship iCAN Partner To Improve Cancer Detection Using an Extensive Biobank Cohort
Genomill and iCAN, the Finnish national cancer research flagship project, signed a partnership aiming to improve the detection of trace tumour DNA from thousands of biobank samples. Genomill, a pioneering…
iCAN flagship partnership in precision cancer medicine launched
iCAN aims for discoveries and improved treatments through research at the interface of precision cancer medicine and digital health. The newly formed partnership, hosted by University of Helsinki and HUS…
iCAN receives 14 million euro grant to promote development of personalized treatments for cancer
iCAN has received a grant of 14 million euros from the Academy of Finland for its second term.